Global drug markets are expanding, diversifying, and adapting through new routes, technologies, substances, and consumer patterns, while public policy often struggles to keep pace. The latest UN report shows that drugs are no longer only a matter of substances, but also of markets, public health, inequality, violence, gender, youth, regulation, and state capacity. The new… Keep Reading
Thirty years into the transition to regulated cannabis markets, teen use and ease of access are at or near the lowest levels ever recorded. It’s prohibition — not legalization — that put kids most at risk. This is an op-ed contribution from Adam J. Smith, Executive Director of the Marijuana Policy Project. The views expressed… Keep Reading
Maine built one of the most vibrant, patient-driven medical cannabis markets in America. Now a contamination panic, a powerful tracking company and a regulatory crackdown threaten to squeeze it into something else entirely. There is a farm in Maine where a woman grows cannabis outdoors, off-grid, on land certified organic by the state’s own agricultural… Keep Reading
